Announcement

Collapse
No announcement yet.

Delayed Conversion to SPMS realized with STRONGER MS Drugs

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

    Delayed Conversion to SPMS realized with STRONGER MS Drugs

    1. In this case-control cohort study, treatment with glatiramer acetate, interferon-beta, fingolimod, alemtuzumab, and natalizumab all led to reduced conversion to secondary progressive Multiple Sclerosis (MS) compared to no Disease-Modifying Treatment (DMT).
    2. Treatment with fingolimod, alemtuzumab, and natalizumab had reduced conversion to secondary progressive MS compared to glatiramer acetate and interferon-beta.


    https://www.2minutemedicine.com/dise...ple-sclerosis/
Working...
X